UK review finds statins are cost effective in secondary preventionBMJ 1999; 319 doi: http://dx.doi.org/10.1136/bmj.319.7222.1390 (Published 27 November 1999) Cite this as: BMJ 1999;319:1390
- Zosia Kmietowicz
Statins are most cost effective when used in patients with evidence of cardiovascular disease, in whom they reduce mortality as well as morbidity, according to a review by an advisory body to the NHS, the Health Technology Assessment.
The review is the 53rd in a series produced by the Health Technology Assessment designed to provide the NHS with information on the most efficient way of using new technologies. Data from five major trials of statins and 18 randomised controlled trials showed that statins reduced overall mortality in people …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial